Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN Cites FDA Indifference Toward DSHEA In Consumer Reports Response

This article was originally published in The Tan Sheet

Executive Summary

Previous FDA unwillingness to properly implement DSHEA is one reason for the absence of major supplement recalls due to safety issues, according to the Council for Responsible Nutrition

You may also be interested in...



IoM Supplement Report Emphasizes Premarket Data, AER Requirements

Dietary supplement manufacturers should be required to submit to FDA all positive and negative premarket safety data on new dietary ingredients, according to the Institute of Medicine's Framework for Evaluating the Safety of Dietary Supplements

Consumer Reports Article Highlights “Dangerous” Supplements

The dietary supplement industry faces more negative publicity after a Consumer Reports article dubbed twelve supplements the "dirty dozen" that consumers should avoid

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel